MyAverix Finance
US · Healthcare
Hard to Treat Diseases Inc (HTDS)
Biotechnology
Hard to Treat Diseases Inc (HTDS) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HTDS
Hard to Treat Diseases Inc (HTDS) — FAQ
What is HTDS's P/E ratio?
The price-to-earnings (P/E) ratio for Hard to Treat Diseases Inc (HTDS) is 18.00 (data as of 2026-03-24).
Does Hard to Treat Diseases Inc pay a dividend?
Dividend yield is not available in the current snapshot for Hard to Treat Diseases Inc (HTDS). Check the MyAverix Finance app for the latest dividend data.
What sector is Hard to Treat Diseases Inc in?
Hard to Treat Diseases Inc (HTDS) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HTDS listed on?
HTDS is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.